CLINICAL-PHARMACOLOGY OF PINDOLOL

被引：26

作者：

AELLIG, WH

机构：

来源：

AMERICAN HEART JOURNAL | 1982年 / 104卷 / 02期

关键词：

D O I：

10.1016/0002-8703(82)90125-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：346 / 356

页数：11

相关论文

共 36 条

[1] ELEVATION OF BETA-ADRENERGIC-RECEPTOR DENSITY IN HUMAN-LYMPHOCYTES AFTER PROPRANOLOL ADMINISTRATION [J].

AARONS, RD ;

NIES, AS ;

GAL, J ;

HEGSTRAND, LR ;

MOLINOFF, PB .

JOURNAL OF CLINICAL INVESTIGATION, 1980, 65 (05) :949-957

[2]

Aellig W H, 1976, Adv Clin Pharmacol, V11, P9

[3]

AELLIG WH, 1977, ACTA MED SCAND, P71

[4] BETA-ADRENOCEPTOR BLOCKING ACTIVITY AND DURATION OF ACTION OF PINDOLOL AND PROPRANOLOL IN HEALTHY VOLUNTEERS [J].

AELLIG, WH .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (02) :251-257

[5]

AELLIG WH, 1980, ARCH INT PHARMACOD T, P32

[6] ACTIVITY AND DURATION OF ACTION OF PINDOLOL AND ALPRENOLOL COMPARED IN HEALTHY VOLUNTEERS [J].

AELLIG, WH .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 14 (05) :305-308

[7] COMPARISON OF DURATION OF ACTION OF PINDOLOL AND SLOW RELEASE OXPRENOLOL IN HEALTHY VOLUNTEERS [J].

AELLIG, WH .

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1978, 14 (03) :167-169

[8]

AELLIG WH, 1979, BASEL HYPERTONI S, V2, P29

[9]

ATTERHOG JH, 1977, ACTA MED SCAND, V202, P517

[10]

BECKER HJ, 1970, AKTUELLE PROBLEME BE, P107

← 1 2 3 4 →